<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD02980000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>Q9Y223</UniProt_ID>
  <Seq_Length>722</Seq_Length>
  <Molecule_Weight>79275</Molecule_Weight>
  <KEGG_ID>hsa:10020</KEGG_ID>
  <Orthology_ID>K12409</Orthology_ID>
  <Function_Summary>Regulates and initiates biosynthesis of N-acetylneuraminic acid (NeuAc), a precursor of sialic acids. Plays an essential role in early development (By similarity). Required for normal sialylation in hematopoietic cells. Sialylation is implicated in cell adhesion, signal transduction, tumorigenicity and metastatic behavior of malignant cells.</Function_Summary>
  <Catalytic_Mechanism>UDP-N-acetyl-D-glucosamine = UDP-N-acetyl-D-mannosamine.@@ATP + N-acyl-D-mannosamine = ADP + N-acyl-D-mannosamine 6-phosphate.</Catalytic_Mechanism>
  <Pfam_ID>PF02350:Epimerase_2@@PF00480:ROK</Pfam_ID>
  <Allosteric_Activator_Count>3</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>1</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Uridine diphosphate-N-acetylglucosamine-2-epimerase</Alias>
      <Alias>UDP-GlcNAc-2-epimerase</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.</Detail>
      <Keyword>Transferase activity</Keyword>
      <Ontology_ID>GO:0016740</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: UDP-N-acetyl-D-glucosamine = UDP-N-acetyl-D-mannosamine.</Detail>
      <Keyword>UDP-N-acetylglucosamine 2-epimerase activity</Keyword>
      <Ontology_ID>GO:0008761</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.</Detail>
      <Keyword>Catalytic activity</Keyword>
      <Ontology_ID>GO:0003824</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.</Detail>
      <Keyword>Kinase activity</Keyword>
      <Ontology_ID>GO:0016301</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: ATP + N-acyl-D-mannosamine = ADP + N-acyl-D-mannosamine 6-phosphate.</Detail>
      <Keyword>N-acylmannosamine kinase activity</Keyword>
      <Ontology_ID>GO:0009384</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.</Detail>
      <Keyword>ATP binding</Keyword>
      <Ontology_ID>GO:0005524</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.</Detail>
      <Keyword>Catalytic activity</Keyword>
      <Ontology_ID>GO:0003824</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the geometric or structural changes within one molecule. Isomerase is the systematic name for any enzyme of EC class 5.</Detail>
      <Keyword>Isomerase activity</Keyword>
      <Ontology_ID>GO:0016853</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>263</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>266</Position>
      <Original>Arg</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>200</Position>
      <Original>Ile</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>576</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>176</Position>
      <Original>Asp</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>206</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>472</Position>
      <Original>Ile</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>460</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>246</Position>
      <Original>Arg</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>378</Position>
      <Original>Asp</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>587</Position>
      <Original>Ile</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>216</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>524</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>696</Position>
      <Original>Val</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>572</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>631</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>600</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>36</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>303</Position>
      <Original>Cys</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>519</Position>
      <Original>Asn</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>557</Position>
      <Original>Ile</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>712</Position>
      <Original>Met</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>171</Position>
      <Original>Met</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>528</Position>
      <Original>Phe</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>631</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>132</Position>
      <Original>His</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>675</Position>
      <Original>Tyr</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>225</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>306</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>630</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>266</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>177</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>246</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>331</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>162</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>27</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving UDP-N-acetylglucosamine, a substance composed of N-acetylglucosamine, a common structural unit of oligosaccharides, in glycosidic linkage with uridine diphosphate.</Detail>
      <Keyword>UDP-N-acetylglucosamine metabolic process</Keyword>
      <Ontology_ID>GO:0006047</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving N-acetylneuraminate, the anion of 5-(acetylamino)-3,5-dideoxy-D-glycero-D-galacto-non-3-ulosonic acid.</Detail>
      <Keyword>N-acetylneuraminate metabolic process</Keyword>
      <Ontology_ID>GO:0006054</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of lipopolysaccharides, any of a group of related, structurally complex components of the outer membrane of Gram-negative bacteria.</Detail>
      <Keyword>Lipopolysaccharide biosynthetic process</Keyword>
      <Ontology_ID>GO:0009103</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.</Detail>
      <Keyword>Cell adhesion</Keyword>
      <Ontology_ID>GO:0007155</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MEKNGNNRKLRVCVATCNRADYSKLAPIMFGIKTEPEFFELDVVVLGSHLIDDYGNTYRMIEQDDFDINTRLHTIVRGEDEAAMVESVGLALVKLPDVLNRLKPDIMIVHGDRFDALALATSAALMNIRILHIEGGEVSGTIDDSIRHAITKLAHYHVCCTRSAEQHLISMCEDHDRILLAGCPSYDKLLSAKNKDYMSIIRMWLGDDVKSKDYIVALQHPVTTDIKHSIKMFELTLDALISFNKRTLVLFPNIDAGSKEMVRVMRKKGIEHHPNFRAVKHVPFDQFIQLVAHAGCMIGNSSCGVREVGAFGTPVINLGTRQIGRETGENVLHVRDADTQDKILQALHLQFGKQYPCSKIYGDGNAVPRILKFLKSIDLQEPLQKKFCFPPVKENISQDIDHILETLSALAVDLGGTNLRVAIVSMKGEIVKKYTQFNPKTYEERINLILQMCVEAAAEAVKLNCRILGVGISTGGRVNPREGIVLHSTKLIQEWNSVDLRTPLSDTLHLPVWVDNDGNCAALAERKFGQGKGLENFVTLITGTGIGGGIIHQHELIHGSSFCAAELGHLVVSLDGPDCSCGSHGCIEAYASGMALQREAKKLHDEDLLLVEGMSVPKDEAVGALHLIQAAKLGNAKAQSILRTAGTALGLGVVNILHTMNPSLVILSGVLASHYIHIVKDVIRQQALSSVQDVDVVVSDLVDPALLGAASMVLDYTTRRIY</Protein_Seq>
    <DNA_Seq>AACTCTATTTTAAGAACCTCTCAAAACGAAACAAGCAAATCATGGAGAAGAATGGAAATAACCGAAAGCTGCGGGTTTGTGTTGCTACTTGTAACCGTGCAGATTATTCTAAACTTGCCCCGATCATGTTTGGCATTAAAACCGAACCTGAGTTCTTTGAACTTGATGTTGTGGTACTTGGCTCTCACCTGATAGATGACTATGGAAATACATATCGAATGATTGAACAAGATGACTTTGACATTAACACCAGGCTACACACAATTGTGAGGGGAGAAGATGAGGCAGCCATGGTGGAGTCAGTAGGCCTGGCCCTAGTGAAGCTGCCAGATGTCCTTAATCGCCTGAAGCCTGATATCATGATTGTTCATGGAGACAGGTTTGATGCCCTGGCTCTGGCCACATCTGCTGCCTTGATGAACATCCGAATCCTTCACATTGAAGGTGGGGAAGTCAGTGGGACCATTGATGACTCTATCAGACATGCCATAACAAAACTGGCTCATTATCATGTGTGCTGCACCCGCAGTGCAGAGCAGCACCTGATATCCATGTGTGAGGACCATGATCGCATCCTTTTGGCAGGCTGCCCTTCCTATGACAAACTTCTCTCAGCCAAGAACAAAGACTACATGAGCATCATTCGCATGTGGCTAGGTGATGATGTAAAATCTAAAGATTACATTGTTGCACTACAGCACCCTGTGACCACTGACATTAAGCATTCCATAAAAATGTTTGAATTAACATTGGATGCACTTATCTCATTTAACAAGCGGACCCTAGTCCTGTTTCCAAATATTGACGCAGGGAGCAAAGAGATGGTTCGAGTGATGCGGAAGAAGGGCATTGAGCATCATCCCAACTTTCGTGCAGTTAAACACGTCCCATTTGACCAGTTTATACAGTTGGTTGCCCATGCTGGCTGTATGATTGGGAACAGCAGCTGTGGGGTTCGAGAAGTTGGAGCTTTTGGAACACCTGTGATCAACCTGGGAACACGTCAGATTGGAAGAGAAACAGGGGAGAATGTTCTTCATGTCCGGGATGCTGACACCCAAGACAAAATATTGCAAGCACTGCACCTTCAGTTTGGTAAACAGTACCCTTGTTCAAAGATATATGGGGATGGAAATGCTGTTCCAAGGATTTTGAAGTTTCTCAAATCTATCGATCTTCAAGAGCCACTGCAAAAGAAATTCTGCTTTCCTCCTGTGAAGGAGAATATCTCTCAAGATATTGACCATATTCTTGAAACTCTAAGTGCCTTGGCCGTTGATCTTGGCGGGACGAACCTCCGAGTTGCAATAGTCAGCATGAAGGGTGAAATAGTTAAGAAGTATACTCAGTTCAATCCTAAAACCTATGAAGAGAGGATTAATTTAATCCTACAGATGTGTGTGGAAGCTGCAGCAGAAGCTGTAAAACTGAACTGCAGAATTTTGGGAGTAGGCATTTCCACAGGTGGCCGTGTAAATCCTCGGGAAGGAATTGTGCTGCATTCAACCAAACTGATCCAAGAGTGGAACTCTGTGGACCTTAGGACCCCCCTTTCTGACACTTTGCATCTCCCTGTGTGGGTAGACAATGATGGCAACTGTGCTGCCCTGGCGGAAAGGAAATTTGGCCAAGGAAAGGGACTGGAAAACTTTGTTACACTTATCACAGGCACAGGAATCGGTGGTGGAATTATCCATCAGCATGAATTGATCCACGGAAGCTCCTTCTGTGCTGCAGAACTGGGCCACCTTGTTGTGTCTCTGGATGGGCCTGATTGTTCCTGTGGAAGCCATGGGTGCATTGAAGCATACGCCTCTGGAATGGCCTTGCAGAGGGAGGCAAAAAAGCTCCATGATGAGGACCTGCTCTTGGTGGAAGGGATGTCAGTGCCAAAAGATGAGGCTGTGGGTGCGCTCCATCTCATCCAAGCTGCGAAACTTGGCAATGCGAAGGCCCAGAGCATCCTAAGAACAGCTGGAACAGCTTTGGGTCTTGGGGTTGTGAACATCCTCCATACCATGAATCCCTCCCTTGTGATCCTCTCCGGAGTCCTGGCCAGTCACTATATCCACATTGTCAAAGACGTCATTCGCCAGCAGGCCTTGTCCTCCGTGCAGGACGTGGATGTGGTGGTTTCGGATTTGGTTGACCCCGCCCTGCTGGGTGCTGCCAGCATGGTTCTGGACTACACAACACGCAGGATCTACTAGACCTCCAGGAACAGACATGGACCTTCTCTCCAGAGCTCCTGAGTGGAATCAAGTTCTTGTCTTTAGGATGACCGTTTCTTAACAATCAAATCTGGTATTGAACTGCAGGTGACTTTGGCAGAGAAATGTTTTCACTTTTGGTCTCCTCTTCCAGAGTCACCTTTCCCCACTCCTATTTTTGTAGATGCTATTCTTTCTGATGTCTTCTTACTAGGGGTCATTTTAGCTCAAACCCTGTAAGTTACAGTCACAATTTTCTGTGCCAAAGCAGCTACAATAATAGAGAGGAAGCCTTCTTAGAACTCTGCTTACTAATGTATTAATACCACTGAGACCTTCAGGCCTTGCTGGGATATCACTTCATCCTGAAGTTTGCATTAATAATCCTTCCAGGCCGGGCACAGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGCGGGCGGATCACGAGGTCAGGAGATCGAGACCGCCCTGGCTAACATGGTGAAACATGGTGAAACCCCGTCTCTACTAAAAATACAAAAAATTAGCTGGGTGTGGTGGCGGGTCCAGCTACTCGGGAGGCTGAGGCAGGAGAATGGCATGAACCCCAGGCTGGAGTGCAGTGGCTCAATGCAACCTCTGCCCCCCGGGTTCGGTGATTCTCCTGCCTCAGCCTCTTGAGTGGCTGGGATTGCGGGCACATGCACCACGCCCGGCTGATTTTTTTTTGTATTTTTAGTGGACAGGGTTTCACCATGTTGGCCAGGCTGGTCTTGAACTCCTGACCTCAGGTGATCCGCCCGCCTCTGCCTCCCAAGGTGCTGGATTACAGGTGTAAGCCATCACACCTGGCCCTAGTGACAGGTTTTTATGGGTACTTTTAGATGATCTAAGAAATCATGTGCATATATCTTTCAGATTTCTATTTTGGAAAATGAAGGTTTCTACAACATATTGTTTCAGTGTTCAAATAAACTGAAGGACTCAACATTACATTTGAACTATATCCTTCCTAGTGGGTTAGTGTGAAAAAGAGTTTGGCTGATTCCTAAAACTCTGCCAGCCCTGCAGTAATCTCCAGGCCTGGTTATTGTTCAGACATTCCATGGTGATTCCTGGGAAGGAAGCTTGGCTGCTCAGTTTCTGAGTCTGGGGTGAGATAATGTTCTGGAAGGACATCTGTTCTTTGGTGTAATCTCTCATGGTGAAATCTGCTCTGTACATCAGACAATTGCATTGCTACCAAGTTTCATACCAAATATTTGAAAGGATGGTATTGAATCTAAACCAAATATTAGGTTTTTATTAAACTCATGGGAAGGCTAATATATTCCAACGTAAATTATTACATATGGTTAAGTAATTGCATGTTAATTTATTTTAATGTAAATATTTTTGTTACTGTTCTGAGCCAAATTCTAAAGAAAAAATAAATACATTTCCTTGTTGAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Pancreas</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Placenta</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Heart</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Brain</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Skeletal muscle</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Liver</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Lung</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Kidney</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>GNE</Gene_Name>
    <Gene_Alias>GLCNE</Gene_Alias>
    <Gene_ID>10020</Gene_ID>
    <Genbank_ACCN>NM_001128227</Genbank_ACCN>
    <Protein_ACCN>NP_001121699</Protein_ACCN>
    <HGNC_ID>23657</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/10020</Gene_URL>
    <UCSC_ID>uc010mlj.3</UCSC_ID>
    <EMBL_ID>ENSG00000159921</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Muscular Dystrophy with Rimmed Vacuoles</Disease_Name>
      <Disease_Detail>Muscular Dystrophy</Disease_Detail>
      <Disease_DB>MSC010</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/muscular_dystrophy_with_rimmed_vacuoles?search=GNE#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Inclusion Body Myositis</Disease_Name>
      <Disease_Detail>Inclusion Body Myositis</Disease_Detail>
      <Disease_DB>INC002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/inclusion_body_myositis?search=GNE#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Paget's Disease of Bone</Disease_Name>
      <Disease_Detail>Paget's Disease of Bone</Disease_Detail>
      <Disease_DB>PGT001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pagets_disease_of_bone?search=GNE#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Oculopharyngodistal Myopathy</Disease_Name>
      <Disease_Detail>Oculopharyngodistal Myopathy</Disease_Detail>
      <Disease_DB>OCL063</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/oculopharyngodistal_myopathy?search=GNE#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sialuria</Disease_Name>
      <Disease_Detail>Sialuria</Disease_Detail>
      <Disease_DB>SLR001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sialuria?search=GNE#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Myopathy</Disease_Name>
      <Disease_Detail>Myopathy</Disease_Detail>
      <Disease_DB>MYP004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/myopathy?search=GNE#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sialuria, French Type</Disease_Name>
      <Disease_Detail>Sialuria, French Type</Disease_Detail>
      <Disease_DB>SLR003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sialuria_french_type?search=GNE#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gne-Related Myopathy</Disease_Name>
      <Disease_Detail>Gne-Related Myopathy</Disease_Detail>
      <Disease_DB>GNR020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gne_related_myopathy?search=GNE#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal structure of the N-acetylmannosamine kinase domain of human GNE protein</PDB_Title>
      <PDB_ID>3EO3</PDB_ID>
      <Resolution>2.84</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3EO3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the N-acetylmannosamine kinase domain of GNE.</PubMed_Title>
      <Author>Tong Y, et al.</Author>
      <Journal>PLoS One.2009 Oct 20;4(10):e7165.</Journal>
      <PubMed_ID>19841673</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko00520</Pathway_ID>
      <Pathway_Title>Amino sugar and nucleotide sugar metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Carbohydrate metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00520</Pathway_ID>
      <Pathway_Title>Amino sugar and nucleotide sugar metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Carbohydrate metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00520</Pathway_ID>
      <Pathway_Title>Amino sugar and nucleotide sugar metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Carbohydrate metabolism</Pathway_Subclass>
    </Network>
  </Network_List>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>range,263,266</Site_Detail>
      <Site_Reference>Seppala R, et al. Am J Hum Genet. 1999,64(6):1563-1569.</Site_Reference>
      <Site_Type>Feedback inhibition allostery</Site_Type>
      <PubMed_ID>10330343</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>5.1.3.14</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC5/1/3/14.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD01330015</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02980001</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02980002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD10298001</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>